Clinical Trials on Opioid Induced Respiratory Depression

Total 2921 results

National Development and Research Institutes, Inc.

Unknown

Applying Web Technology to Buprenorphine Treatment

Adult Opioid-Dependence

United States
University of Chicago
Community Outreach Intervention Projects; Cook County Sheriff Office; Cook County... and other collaborators

Recruiting

Reducing Opioid Mortality in Illinois (ROMI)

Opioid Use | Opioid-use Disorder

United States
University of Colorado, Denver
American Academy of Family Physicians National Research Network

Active, not recruiting

Comparing Home, Office, and Telehealth Induction for Medication Assisted Treatment for Opioid Use Disorder (HOMER)

Opioid Dependence | Opioid-use Disorder

United States
Sunnybrook Health Sciences Centre

Completed

Investigation of the Effects of Repetitive Transcranial Magnetic Stimulation on Cognition in Depression

Major Depressive Disorder | Treatment Resistant Depression

Canada
RAND
National Institute of Mental Health (NIMH); University of Pittsburgh; Boston... and other collaborators

Active, not recruiting

Collaboration Leading to Addiction Treatment and Recovery From Other Stresses (CLARO)

Depression | Addiction | Opioid-use Disorder | Post-traumatic Stress Disorder

United States
University of Texas at Austin
Substance Abuse and Mental Health Services Administration (SAMHSA)

Completed

Resonance Breathing Intervention Opioid Use Disorder

Substance-Related Disorders

United States
Instituto Nacional de Psiquiatría Dr. Ramón de...

Completed

Clinical Studies on the Therapeutic Effects of Mirtazapine on Drug-craving in Cocaine Addicts. (MADC)

Drug-withdrawal. | Drug Abuse | Drug-induced Depressive State | AOD Craving | AODR Depressive State

Mexico
NEMA Research, Inc.

Not yet recruiting

ENA-001 for Post Operative Respiratory Depression (PORD)

Respiratory Depression
University College Dublin

Completed

The Use of Low Dose Prophylactic Naloxone Infusion to Prevent Respiratory Depression With Intrathecal Morphine. (NAPRESSIM)

Respiratory Depression

Ireland
Yale University
Thrasher Research Fund

Completed

Detecting Post-Operative Respiratory Depression in Children

Respiratory Depression

United States
HealthPartners Institute
National Institute on Drug Abuse (NIDA); Hennepin Healthcare Research Institute

Completed

Comparing Two Training Methods for Opioid Wizard

Opioid Dependence | Opioid-use Disorder | Attitude of Health Personnel

United States
Christal L Badour

Completed

Trauma and Trauma-Focused Therapy in the University of Kentucky SMART Clinic

PTSD | Substance Use Disorders | Opioid-use Disorder

United States
AstraZeneca

Completed

A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced Constipation

Opioid-Induced Constipation (OIC)

United States, Germany, Australia, Slovakia
AstraZeneca
Nektar Therapeutics

Completed

A Phase 2, Double-Blind, Multiple-Dose Escalation Study to Evaluate NKTR-118 (Oral PEG-Naloxol) in Patients With Opioid-Induced Constipation (OIC)

Opioid Induced Constipation (OIC)

United States
Women and Infants Hospital of Rhode Island
National Institute on Drug Abuse (NIDA)

Completed

Sober Network IPT for Perinatal Women With Comorbid Substance Use and Depression

Perinatal Depression, Substance Use

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Medications Development for Drug Abuse Disorders

Opioid Dependence | Opioid Related Disorders | Opioid Addiction

United States
Prisma Health-Upstate
Clemson University

Recruiting

CBT4CBT-Buprenorphine + Recovery Coach for Office-based Buprenorphine

Opioid-use Disorder

United States
University of California, Irvine

Recruiting

Adapting the HOPE Online Support Intervention to Increase Uptake of Medications for Opioid Use Disorder (HOPE MOUD)

Opioid-use Disorder

United States
InSightec

Recruiting

Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD)

Opioid-use Disorder

United States
New York State Psychiatric Institute
University of New Mexico

Completed

Culturally Centering Medications for Opioid Use Disorder With American Indian and Alaska Native Communities (CTN-0096)

Opioid-use Disorder

United States
Milton S. Hershey Medical Center
Columbia University; National Institutes of Health (NIH); Research Foundation... and other collaborators

Active, not recruiting

reSET-O RCT (Randomized Controlled Trial)

Opioid-use Disorder

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Cannabidiol Effects on Craving and Relapse Prevention in Opioid Use Disorder

Opioid-use Disorder

United States
Massachusetts General Hospital

Terminated

Mindfulness Oriented Recovery Enhancement in Hospitalized People With Opioid Use Disorder

Opioid-use Disorder

United States
Johns Hopkins University
Centers for Disease Control and Prevention

Completed

Buprenorphine Treatment Engagement and Overdose Prevention

Opioid-use Disorder

United States
Dartmouth-Hitchcock Medical Center
National Center for Complementary and Integrative Health (NCCIH); Trustees...

Completed

Mindful Moms in Recovery (MMORE)

Opioid-use Disorder

United States
Johns Hopkins University
Patient-Centered Outcomes Research Institute

Active, not recruiting

Contingency Management to Enhance Office-Based Buprenorphine Treatment

Opioid-use Disorder

United States
Karen Derefinko, PhD
National Center for Complementary and Integrative Health (NCCIH); University... and other collaborators

Enrolling by invitation

SMART Trial for Buprenorphine-Naloxone Medication Assisted Treatment Adherence

Opioid-use Disorder

United States
BioCorRx Inc
National Institute on Drug Abuse (NIDA); The HEAL Initiative (https://heal.nih...

Completed

Pharmacokinetic and Safety Study of Naltrexone Release From Subcutaneous BICX104 Pellets Compared to Vivitrol Injections

Opioid-use Disorder

United States
Orexo AB

Completed

OXD01 in Combination With Sublingual Buprenorphine/Naloxone for Treatment of Opioid Use Disorder

Opioid-use Disorder

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Rural MOUD Telemedicine in Primary Care Phase 1 (Feasibility)

Opioid-use Disorder

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA); Baltimore City Health Department

Enrolling by invitation

Opioid Use Disorder Treatment Linkage at Sexual Health Clinics Using Buprenorphine (OUTLAST-B)

Opioid-use Disorder

United States
Lars Tanum
Oslo University Hospital; Haukeland University Hospital; The Hospital of Vestfold and other collaborators

Completed

Long Acting Naltrexone for Opioid Addiction: Focus on Sustained Abstinence and Recovery (NaltRec)

Opioid-use Disorder

Norway
Boston Medical Center
Substance Abuse and Mental Health Services Administration (SAMHSA)

Terminated

Response to Relapse in Office-Based Opioid Treatment Trial (RR-OBOT)

Opioid-use Disorder

United States
Alar Pharmaceuticals Inc.

Completed

Single Ascending Dose Study of ALA-1000

Opioid-use Disorder

United States
New York State Psychiatric Institute
USWM, LLC (dba US WorldMeds)

Completed

Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment

Opioid-use Disorder

United States
University of Maryland, Baltimore

Withdrawn

Safety and Preliminary Efficacy of ANS-6637 to Reduce Drug Craving and Harm in People With Opioid Use Disorder (SEARCH)

Opioid-use Disorder
University of Wisconsin, Madison
National Institute on Drug Abuse (NIDA)

Completed

Intervention to Expand Opioid Use Disorder Treatment Pharmacotherapy Prescribers

Opioid-use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Evaluation of Intranasal Naltrexone and Naloxone

Opioid-use Disorder
Stony Brook University

Withdrawn

Buprenorphine vs Buprenorphine/Naloxone on the Effects of Maternal Symptomatology

Opioid-use Disorder
University of California, Los Angeles
Alkermes, Inc.

Completed

Injectable Pharmacotherapy for Opioid Use Disorders (IPOD) (IPOD)

Opioid Use Disorders

United States
Braeburn Pharmaceuticals

Completed

Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence

Opioid Use Disorders

United States
University of Vermont

Unknown

Interim Buprenorphine Treatment to Bridge Waitlist Delays: Stage II Evaluation

Opioid-use Disorder

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

RCT Comparing Methadone and Buprenorphine in Pregnant Women

Pregnancy | Opioid Dependence | Opioid Related Disorders

United States, Canada, Austria
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Unknown

Study of Opioid Immunosuppressive Effects

Opioid Abuse or Dependence
University of Vermont Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Effective Treatment for Prescription Opioid Abuse

Prescription Opioid Dependence

United States
Rowan University
The Cooper Health System

Recruiting

Increasing MAT Engagement With Financial Incentives

Opioid-use Disorder

United States
New York State Psychiatric Institute
Clinilabs, Inc.

Recruiting

Clinical Trials of Multivalent Opioid Vaccine Components

Opioid-use Disorder

United States
Friends Research Institute, Inc.

Recruiting

Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail

Opioid-use Disorder

United States
Allegheny Singer Research Institute (also known...
Abbott

Recruiting

Deep Brain Stimulation Effects In Patients With Opioid Use Disorder

Opioid-use Disorder

United States
National Institute on Drug Abuse (NIDA)

Recruiting

Biased Opioid Agonists for Treatment of Opioid Withdrawal in OUD

Opioid-Use Disorder

United States

Clinical Trials on Opioid Induced Respiratory Depression

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations